MySmarTrend
← Insider Monitor
CRISPR Therapeutics AG logo
CRSP

CRISPR Therapeutics AG

Nasdaq · Biological Products, (No Diagnostic Substances)

1
Insider trades
0
Congress trades

Company Overview

A concise company profile alongside the latest public filing activity.

CRISPR Therapeutics is a gene-editing company that develops therapies based on CRISPR/Cas9 technology, including treatments for sickle cell disease and beta thalassemia, and is advancing programs in oncology, diabetes, and cardiovascular disease.

Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Zug
Exchange
Nasdaq

Company profile sourced from SEC filings.

Corporate Insider Trades

Open-market purchases and sales by directors, officers, and other company insiders.

InsiderTypeValueDate
Behbahani AliInsiderSell$781KSep 17, 2026

Source: SEC EDGAR Form 4 filings

Congressional Trades

Recent disclosures by members of the U.S. House and Senate.

No recent congressional disclosures found for CRSP.

Source: Senate eFD and House Clerk STOCK Act disclosures

Get notable CRSP activity by email

Free alerts for the insider and congressional trades worth watching.

By submitting your email address, you will receive a free subscription to the MySmarTrend e-letter, and offers from us and our affiliates that we think might interest you. You can unsubscribe at any time. Privacy Policy.

For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.